Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)
NCT00626444
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Stopped
Slow accrual
Conditions
Non-Hodgkin Lymphoma
Interventions
DRUG:
Intravenous vitamin C
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University